Trials / Completed
CompletedNCT01702636
STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial
STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Neuroscience Trials Australia · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to test if intracerebral haemorrhage (ICH) patients who have contrast extravasation on computed tomography angiography, the "spot sign", have lower rates of haematoma growth when treated with tranexamic acid within 4.5 hours of stroke onset, compared to placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tranexamic Acid | |
| DRUG | Placebo |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2019-08-14
- Completion
- 2019-12-01
- First posted
- 2012-10-08
- Last updated
- 2020-02-26
Locations
11 sites across 2 countries: Australia, Finland
Source: ClinicalTrials.gov record NCT01702636. Inclusion in this directory is not an endorsement.